Anatomy and Cell Biology

  • 제44권2호
  • /
  • Pages.116-127
  • /
  • 2011
  • /
  • 2093-3665(pISSN)
  • /
  • 2093-3673(eISSN)
대한해부학회 (Korean Association of Anatomists)
권호 표지
DOI QR코드

DOI QR Code

Expression of $ErbB_4$ in the neurons of Alzheimer's disease brain and $APP/PS_1$ mice, a model of Alzheimer's disease

  • Woo, Ran-Sook (Department of Anatomy and Neuroscience, College of Medicine, Eulji University) ;
  • Lee, Ji-Hye (Department of Anatomy and Neuroscience, College of Medicine, Eulji University) ;
  • Yu, Ha-Nul (Department of Anatomy and Neuroscience, College of Medicine, Eulji University) ;
  • Song, Dae-Yong (Department of Anatomy and Neuroscience, College of Medicine, Eulji University) ;
  • Baik, Tai-Kyoung (Department of Anatomy and Neuroscience, College of Medicine, Eulji University)
  • 발행 : 2011.06.30
⟨ 이전 논문 다음 논문 ⟩

초록

Neuregulin-1 (NRG1) plays important roles in the development and plasticity of the brain, and has also been reported to exhibit potent neuroprotective properties. Although ErbB4, a key NRG1 receptor, is expressed in multiple regions in the adult animal brain, little is known about its role in Alzheimer's disease (AD). AD is characterized by progressive impairment of cognition and behavioral disturbance that strongly correlate with degeneration and death of neurons in the cerebral cortex and limbic brain areas, such as the hippocampus and the amygdala. Here, we show that the ErbB4 and phospho- ErbB4 immunoreactivities were higher intensity in the neurons of the CA1-2 transitional field of AD brains as compared to agematched controls. Also, ErbB4 expression was increased in the neurons of the cortico medial nucleus amygdala, human basal forebrain and superior frontal gyrus of AD brains. In cerebral cortex and hippocampus of amyloid precursor protein/presenilin 1 double transgenic mice, ErbB4 immunoreactivity significantly increased in comparison to age-matched wild type control. These results suggest that up-regulating of ErbB4 immunoreactivity may involve in the progression of pathology of AD.

키워드

참고문헌

  1. Tilley L, Morgan K, Kalsheker N. Genetic risk factors in Alzheimer's disease. Mol Pathol 1998;51:293-304. https://doi.org/10.1136/mp.51.6.293
  2. Morrissette DA, Parachikova A, Green KN, LaFerla FM. Relevance of transgenic mouse models to human Alzheimer disease. J Biol Chem 2009;284:6033-7. https://doi.org/10.1074/jbc.R800030200
  3. Buonanno A, Fischbach GD. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol 2001;11:287-96. https://doi.org/10.1016/S0959-4388(00)00210-5
  4. Corfas G, Roy K, Buxbaum JD. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 2004;7:575-80. https://doi.org/10.1038/nn1258
  5. Anton ES, Marchionni MA, Lee KF, Rakic P. Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 1997;124:3501-10.
  6. Rio C, Rieff HI, Qi P, Khurana TS, Corfas G. Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron 1997;19:39-50. https://doi.org/10.1016/S0896-6273(00)80346-3
  7. Fernandez PA, Tang DG, Cheng L, Prochiantz A, Mudge AW, Raff MC. Evidence that axon-derived neuregulin promotes oligodendrocyte survival in the developing rat optic nerve. Neuron 2000;28:81-90. https://doi.org/10.1016/S0896-6273(00)00087-8
  8. Calaora V, Rogister B, Bismuth K, Murray K, Brandt H, Leprince P, Marchionni M, Dubois-Dalcq M. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J Neurosci 2001;21:4740-51.
  9. Lopez-Bendito G, Cautinat A, Sanchez JA, Bielle F, Flames N, Garratt AN, Talmage DA, Role LW, Charnay P, Marin O, Garel S. Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell 2006;125:127-42. https://doi.org/10.1016/j.cell.2006.01.042
  10. Bermingham-McDonogh O, McCabe KL, Reh TA. Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina. Development 1996;122:1427-38.
  11. Gerecke KM, Wyss JM, Carroll SL. Neuregulin-1beta induces neurite extension and arborization in cultured hippocampal neurons. Mol Cell Neurosci 2004;27:379-93. https://doi.org/10.1016/j.mcn.2004.08.001
  12. Li B, Woo RS, Mei L, Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007;54:583-97. https://doi.org/10.1016/j.neuron.2007.03.028
  13. Bublil EM, Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin Cell Biol 2007;19:124-34. https://doi.org/10.1016/j.ceb.2007.02.008
  14. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2:127-37. https://doi.org/10.1038/35052073
  15. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003;284:14-30. https://doi.org/10.1016/S0014-4827(02)00102-7
  16. Yau HJ, Wang HF, Lai C, Liu FC. Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb Cortex 2003;13:252-64. https://doi.org/10.1093/cercor/13.3.252
  17. Woo RS, Li XM, Tao Y, Carpenter-Hyland E, Huang YZ, Weber J, Neiswender H, Dong XP, Wu J, Gassmann M, Lai C, Xiong WC, Gao TM, Mei L. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 2007;54:599-610. https://doi.org/10.1016/j.neuron.2007.04.009
  18. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002;71:877-92. https://doi.org/10.1086/342734
  19. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006;60:132-40. https://doi.org/10.1016/j.biopsych.2005.11.002
  20. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci U S A 2006;103:6747-52. https://doi.org/10.1073/pnas.0602002103
  21. Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet 2006;141B:142-8. https://doi.org/10.1002/ajmg.b.30275
  22. DeMichele-Sweet MA, Sweet RA. Genetics of psychosis in Alzheimer's disease: a review. J Alzheimers Dis 2010;19:761-80. https://doi.org/10.3233/JAD-2010-1274
  23. Go RC, Perry RT, Wiener H, Bassett SS, Blacker D, Devlin B, Sweet RA. Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses. Am J Med Genet B Neuropsychiatr Genet 2005;139B:28-32. https://doi.org/10.1002/ajmg.b.30219
  24. Campbell SK, Switzer RC, Martin TL. Alzheimers paques and tangles: a controlled and enhanced silver staining method. Abstr Soc Neurosci 1987;13:678.
  25. Gallyas F. Silver staining of Alzheimer's neurofi brillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971;19:1-8.
  26. Murata K, Dalakas MC. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in infl ammatory myopathies. Am J Pathol 1999;155:453-60. https://doi.org/10.1016/S0002-9440(10)65141-3
  27. Schnell SA, Staines WA, Wessendorf MW. Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 1999;47:719-30. https://doi.org/10.1177/002215549904700601
  28. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 1991;82:239-59. https://doi.org/10.1007/BF00308809
  29. Di Segni A, Shaharabani E, Stein R, Pinkas-Kramarski R. Neuregulins rescue PC12-ErbB-4 cells from cell death induced by beta-amyloid peptide: involvement of PI3K and PKC. J Mol Neurosci 2005;26:57-69. https://doi.org/10.1385/JMN:26:1:057
  30. Chaudhury AR, Gerecke KM, Wyss JM, Morgan DG, Gordon MN, Carroll SL. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol 2003;62:42-54. https://doi.org/10.1093/jnen/62.1.42
  31. Wu CK, Thal L, Pizzo D, Hansen L, Masliah E, Geula C. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease. Exp Neurol 2005;195:484-96. https://doi.org/10.1016/j.expneurol.2005.06.020
  32. Morrison JH. Differential vulnerability, connectivity, and cell typology. Neurobiol Aging 1993;14:51-4. https://doi.org/10.1016/0197-4580(93)90021-3
  33. Giannakopoulos P, Hof PR, Bouras C. Selective vulnerability of neocortical association areas in Alzheimer's disease. Microsc Res Tech 1998;43:16-23. https://doi.org/10.1002/(SICI)1097-0029(19981001)43:1<16::AID-JEMT3>3.0.CO;2-T
  34. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996;16:4491-500.
  35. Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science 1997;278:412-9. https://doi.org/10.1126/science.278.5337.412
  36. Emre M, Heckers S, Mash DC, Geula C, Mesulam MM. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease. J Comp Neurol 1993;336:117-34. https://doi.org/10.1002/cne.903360110
  37. Lai C, Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 1991;6:691-704. https://doi.org/10.1016/0896-6273(91)90167-X
  38. Woo RS, Lee JH, Yu HN, Song DY, Baik TK. Expression of ErbB4 in the apoptotic neurons of Alzheimer's disease brain. Anat Cell Biol 2010;43:332-9. https://doi.org/10.5115/acb.2010.43.4.332
  39. Thompson M, Lauderdale S, Webster MJ, Chong VZ, Mc-Clintock B, Saunders R, Weickert CS. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res 2007;1139:95-109. https://doi.org/10.1016/j.brainres.2006.11.047
  40. Bernstein HG, Lendeckel U, Bertram I, Bukowska A, Kanakis D, Dobrowolny H, Stauch R, Krell D, Mawrin C, Budinger E, Keilhoff G, Bogerts B. Localization of neuregulin-1alpha (heregulin-alpha) and one of its receptors, ErbB-4 tyrosine kinase, in developing and adult human brain. Brain Res Bull 2006;69:546-59. https://doi.org/10.1016/j.brainresbull.2006.02.017
  41. Wyeth MS, Zhang N, Mody I, Houser CR. Selective reduction of cholecystokinin-positive basket cell innervation in a model of temporal lobe epilepsy. J Neurosci 2010;30:8993-9006. https://doi.org/10.1523/JNEUROSCI.1183-10.2010
  42. Li BS, Ma W, Jaffe H, Zheng Y, Takahashi S, Zhang L, Kulkarni AB, Pant HC. Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J Biol Chem 2003;278:35702-9. https://doi.org/10.1074/jbc.M302004200
  43. Ricart K, Pearson RJ Jr, Viera L, Cassina P, Kamaid A, Carroll SL, Estevez AG. Interactions between beta-neuregulin and neurotrophins in motor neuron apoptosis. J Neurochem 2006;97:222-33. https://doi.org/10.1111/j.1471-4159.2006.03739.x
  44. Zhang L, Fletcher-Turner A, Marchionni MA, Apparsundaram S, Lundgren KH, Yurek DM, Seroogy KB. Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures. J Neurochem 2004;91:1358-68. https://doi.org/10.1111/j.1471-4159.2004.02817.x
  45. Stankovic K, Rio C, Xia A, Sugawara M, Adams JC, Liberman MC, Corfas G. Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear. J Neurosci 2004;24:8651-61. https://doi.org/10.1523/JNEUROSCI.0733-04.2004
  46. Goldshmit Y, Erlich S, Pinkas-Kramarski R. Neuregulin rescues PC12-ErbB4 cells from cell death induced by H(2)O(2). Regulation of reactive oxygen species levels by phosphatidylinositol 3-kinase. J Biol Chem 2001;276:46379-85. https://doi.org/10.1074/jbc.M105637200
  47. Shyu WC, Lin SZ, Chiang MF, Yang HI, Thajeb P, Li H. Neuregulin-1 reduces ischemia-induced brain damage in rats. Neurobiol Aging 2004;25:935-44. https://doi.org/10.1016/j.neurobiolaging.2003.10.012
  48. Li Y, Xu Z, Ford GD, Croslan DR, Cairobe T, Li Z, Ford BD. Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia. Brain Res 2007;1184:277-83. https://doi.org/10.1016/j.brainres.2007.09.037
  49. Croslan DR, Schoell MC, Ford GD, Pulliam JV, Gates A, Clement CM, Harris AE, Ford BD. Neuroprotective effects of neuregulin-1 on B35 neuronal cells following ischemia. Brain Res 2008;1210:39-47. https://doi.org/10.1016/j.brainres.2008.02.059
  50. Ni CY, Murphy MP, Golde TE, Carpenter G. gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001;294:2179-81. https://doi.org/10.1126/science.1065412
  51. Lee HJ, Jung KM, Huang YZ, Bennett LB, Lee JS, Mei L, Kim TW. Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. J Biol Chem 2002;277:6318-23. https://doi.org/10.1074/jbc.M110371200
  52. Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 2006;9:1520-5. https://doi.org/10.1038/nn1797
  53. Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, DeStrooper B, Saftig P, Birchmeier C, Haass C. Control of peripheral nerve myelination by the beta-secretase BACE1. Science 2006;314:664-6. https://doi.org/10.1126/science.1132341
  54. Savonenko AV, Melnikova T, Laird FM, Stewart KA, Price DL, Wong PC. Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc Natl Acad Sci U S A 2008;105:5585-90. https://doi.org/10.1073/pnas.0710373105

피인용 문헌

  1. Neuregulin-1 Exerts Protective Effects Against Neurotoxicities Induced by C-Terminal Fragments of APP via ErbB4 Receptor vol.119, pp.1, 2012, https://doi.org/10.1254/jphs.12057fp
  2. EGFR signaling in the brain is necessary for olfactory learning in Drosophila larvae vol.20, pp.4, 2011, https://doi.org/10.1101/lm.029934.112
  3. Neuregulin1beta1 Antagonizes Apoptosis Via ErbB4-Dependent Activation of PI3-Kinase/Akt in APP/PS1 Transgenic Mice vol.38, pp.11, 2013, https://doi.org/10.1007/s11064-013-1131-z
  4. The reemergence of long-term potentiation in aged Alzheimer’s disease mouse model vol.6, pp.None, 2011, https://doi.org/10.1038/srep29152
  5. Curcumin Exerts Effects on the Pathophysiology of Alzheimer’s Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression vol.8, pp.None, 2011, https://doi.org/10.3389/fneur.2017.00531
  6. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer’s disease: possible mechanisms of IDE in T2D and AD vol.38, pp.1, 2018, https://doi.org/10.1042/bsr20170862
  7. GLP-1 receptor regulates cell growth through regulating IDE expression level in Aβ1–42-treated PC12 cells vol.38, pp.4, 2011, https://doi.org/10.1042/bsr20171284
  8. Ablation of ErbB4 in parvalbumin‐positive interneurons inhibits adult hippocampal neurogenesis through down‐regulating BDNF/TrkB expression vol.526, pp.15, 2018, https://doi.org/10.1002/cne.24506
  9. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs Cardioprotection vol.9, pp.None, 2019, https://doi.org/10.3389/fcimb.2019.00265
  10. Receptor tyrosine kinases (RTKs) consociate in regulatory clusters in Alzheimer’s disease and type 2 diabetes vol.459, pp.1, 2011, https://doi.org/10.1007/s11010-019-03560-5
  11. Pathological analysis of ErbB family and NRG-1 protein in progressive supranuclear palsy vol.70, pp.None, 2011, https://doi.org/10.5361/jkmu.70.13
  12. A novel estimator of between-study variance in random-effects models vol.21, pp.1, 2011, https://doi.org/10.1186/s12864-020-6500-9
  13. Neuregulins in Neurodegenerative Diseases vol.13, pp.None, 2021, https://doi.org/10.3389/fnagi.2021.662474
  14. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach vol.6, pp.21, 2011, https://doi.org/10.1021/acsomega.1c01526
  15. ErbB4 mediates amyloid β‐induced neurotoxicity through JNK/tau pathway activation: Implications for Alzheimer's disease vol.529, pp.15, 2011, https://doi.org/10.1002/cne.25207
  16. The Prevailing Role of Topoisomerase 2 Beta and its Associated Genes in Neurons vol.58, pp.12, 2011, https://doi.org/10.1007/s12035-021-02561-0
  17. MicroRNA-Target Interaction Regulatory Network in Alzheimer’s Disease vol.11, pp.12, 2011, https://doi.org/10.3390/jpm11121275